Arnold Porter Advises Corstasis in Sale to Esperion

In its final agreement to be purchased by publicly traded biopharmaceutical business Esperion Therapeutics, Inc., Corstasis Therapeutics Inc., a privately held commercial-stage biopharmaceutical company, received advice from Arnold & Porter.